List of insiders holdings for BeOne Medicines Ltd.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 2026-06-15 16:40:14 | 115,912,814 0 | 115,912,814 | Form 13D |
| 2 | BAKER BROS. ADVISORS LP 14159 L.P. Baker Bros. Advisors (GP) LLC BAKER JULIAN BAKER FELIX 667 L.P. Baker Brothers Life Sciences LP Director 10% Owner | 2026-06-15 16:40:14 | 115,912,814 0 | 115,912,814 | Form 13D |
| 3 | HHLR ADVISORS LTD. HILLHOUSE INVESTMENT MANAGEMENT LTD. 10% Owner | 2025-05-13 16:15:10 | 68,551,141 0 | 68,551,141 | Form 13D |
| 4 | OYLER JOHN Chief Executive Officer | 2026-08-12 17:53:28 | 1,330,988 46,031,994 | 47,362,982 | Form 4 |
| 5 | CB Biotech Investment Ltd CPEChina Fund L.P. CITIC PE Associates L.P. CITIC PE Funds Ltd 10% Owner | 2016-02-09 20:07:35 | 19,601,138 0 | 19,601,138 | Form 4 |
| 6 | AMGEN INC 10% Owner | 2021-09-13 19:27:07 | 18,943,802 0 | 18,943,802 | Form 4 |
| 7 | Wang Xiaodong Chair, Scientific Advisory Brd | 2026-09-10 16:49:55 | 5,798,192 4,978,213 | 10,776,405 | Form 4 |
| 8 | Glazer Donald W. Director | 2024-06-07 16:58:01 | 2,752,615 0 | 2,752,615 | Form 4 |
| 9 | Li Ji EVP and Gl. Head of Bus. Dev. | 2018-03-02 18:41:22 | 2,721,000 0 | 2,721,000 | Form 4 |
| 10 | Wang Lai President, Global Head of R&D | 2026-06-25 17:14:55 | 1,681,004 601,965 | 2,282,969 | Form 4 |
| 11 | Peterson Amy C. CMO, Immuno-oncology | 2018-12-19 18:34:10 | 1,966,402 0 | 1,966,402 | Form 4 |
| 12 | Liang Howard CFO & Chief Strategy Officer | 2021-06-30 16:45:49 | 1,553,149 0 | 1,553,149 | Form 4 |
| 13 | Wu Xiaobin President and COO | 2026-08-27 17:12:32 | 1,282,449 4,000 | 1,286,449 | Form 4 |
| 14 | Yang Jianxin Sr. VP, Head of Clinical Dev. | 2016-07-15 16:34:25 | 825,000 0 | 825,000 | Form 4 |
| 15 | Yan Wendy Xiaojun Sr. VP, Head of Reg. Affairs | 2016-07-15 16:30:50 | 825,000 0 | 825,000 | Form 4 |
| 16 | Lee Chan Henry SVP, General Counsel | 2026-08-13 20:54:38 | 471,263 0 | 471,263 | Form 4 |
| 17 | Wang Julia Aijun Chief Financial Officer | 2024-07-03 17:05:32 | 426,595 0 | 426,595 | Form 4 |
| 18 | Rosenberg Aaron Chief Financial Officer | 2026-08-05 17:15:58 | 382,850 0 | 382,850 | Form 4 |
| 19 | Huang Jane CMO, Hematology | 2021-12-16 17:50:15 | 371,331 0 | 371,331 | Form 4 |
| 20 | Tang Ke Director | 2017-04-21 16:42:20 | 199,992 0 | 199,992 | Form 4 |
| 21 | Yuan RuiRong Chief Medical Officer | 2016-02-09 20:08:35 | 130,000 0 | 130,000 | Form 4 |
| 22 | Malley Thomas Director | 2023-06-20 19:00:29 | 103,671 0 | 103,671 | Form 4 |
| 23 | Ball Titus B. Principal Accounting Officer | 2026-09-03 17:17:16 | 97,929 0 | 97,929 | Form 4 |
| 24 | HOOPER ANTHONY C Director | 2026-06-15 17:50:59 | 83,720 0 | 83,720 | Form 4 |
| 25 | Riva Alessandro Director | 2026-06-15 17:49:24 | 73,164 0 | 73,164 | Form 4 |
| 26 | Dugan Margaret Director | 2026-06-15 17:50:48 | 73,164 0 | 73,164 | Form 4 |
| 27 | Sanders Corazon (Corsee) D. Director | 2026-05-27 17:26:06 | 54,470 0 | 54,470 | Form 4 |
| 28 | BRANDICOURT OLIVIER Director | 2026-06-15 17:51:05 | 46,306 0 | 46,306 | Form 4 |
| 29 | Sharp Shalini Director | 2026-06-15 17:49:39 | 38,125 0 | 38,125 | Form 4 |
| 30 | Chen Timothy Yung-Cheng Director | 2021-06-21 16:42:08 | 25,298 0 | 25,298 | Form 4 |
| 31 | su Jingshyh S Director | 2021-06-21 16:34:12 | 25,298 0 | 25,298 | Form 4 |
| 32 | Yi Qingqing Director | 2026-06-03 16:10:26 | 24,271 0 | 24,271 | Form 4 |
| 33 | Sawyers Charles Lazelle Director | 2026-06-15 17:49:46 | 20,930 0 | 20,930 | Form 4 |
| 34 | Mooney Elizabeth Fisher Director | 2026-06-15 17:50:54 | 18,980 0 | 18,980 | Form 4 |
| 35 | GOLLER MICHAEL Director | 2016-02-02 19:40:27 | 0 0 | 0 | Form 3 |
| 36 | Merck & Co. Inc. Merck Sharp & Dohme Corp. Merck Sharp & Dohme Research GmbH 10% Owner | 2018-02-13 16:29:07 | 0 0 | 0 | Form 13G |
| 37 | KRISHANA RANJEEV Director | 2016-02-02 19:14:15 | 0 0 | 0 | Form 3 |